326 related articles for article (PubMed ID: 6304836)
1. Clinical and serological response of sheep to serial challenge with different bluetongue virus types.
Jeggo MH; Gumm ID; Taylor WP
Res Vet Sci; 1983 Mar; 34(2):205-11. PubMed ID: 6304836
[TBL] [Abstract][Full Text] [Related]
2. Serial inoculation of sheep with two bluetongue virus types.
Jeggo MH; Wardley RC; Brownlie J; Corteyn AH
Res Vet Sci; 1986 May; 40(3):386-92. PubMed ID: 3016851
[TBL] [Abstract][Full Text] [Related]
3. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
Wade-Evans AM; Romero CH; Mellor P; Takamatsu H; Anderson J; Thevasagayam J; Fleming MJ; Mertens PP; Black DN
Virology; 1996 Jun; 220(1):227-31. PubMed ID: 8659119
[TBL] [Abstract][Full Text] [Related]
4. Clinical and serological outcome following the simultaneous inoculation of three bluetongue virus types into sheep.
Jeggo MH; Wardley RC; Taylor WP
Res Vet Sci; 1984 Nov; 37(3):368-70. PubMed ID: 6097969
[TBL] [Abstract][Full Text] [Related]
5. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
[TBL] [Abstract][Full Text] [Related]
6. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.
Oura CA; Wood JL; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Floyd T; Simmons H; Batten CA
Vaccine; 2009 Dec; 27(52):7326-30. PubMed ID: 19786141
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
[TBL] [Abstract][Full Text] [Related]
8. Immunologic response of sheep to inactivated and virulent bluetongue virus.
Stott JL; Barber TL; Osburn BI
Am J Vet Res; 1985 May; 46(5):1043-9. PubMed ID: 2988376
[TBL] [Abstract][Full Text] [Related]
9. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
[TBL] [Abstract][Full Text] [Related]
10. Potency and efficacy of inactivated bluetongue virus vaccines.
Stevens DR; Stott J; Osburn BI; Giles R; Wiesehahn GP; Barber TL
Prog Clin Biol Res; 1985; 178():649-52. PubMed ID: 2989914
[TBL] [Abstract][Full Text] [Related]
11. Use of a quadrivalent modified-live bluetongue virus vaccine in wildlife species.
McConnell S; Morrill JC; Livingston CW
Prog Clin Biol Res; 1985; 178():631-8. PubMed ID: 2989912
[TBL] [Abstract][Full Text] [Related]
12. Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine.
Oura CA; Wood JL; Floyd T; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Simmons H; Batten CA
Vaccine; 2010 Mar; 28(15):2749-53. PubMed ID: 20123052
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
[TBL] [Abstract][Full Text] [Related]
14. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
[TBL] [Abstract][Full Text] [Related]
15. Experimental bluetongue infections in gnotobiotic lambs and kids.
Livingston CW; McConnell S; Cummings G; Gauer BB
Am J Vet Res; 1983 Jan; 44(1):129-31. PubMed ID: 6297338
[TBL] [Abstract][Full Text] [Related]
16. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD
Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568
[TBL] [Abstract][Full Text] [Related]
17. Role of neutralising antibody in passive immunity to bluetongue infection.
Jeggo MH; Wardley RC; Taylor WP
Res Vet Sci; 1984 Jan; 36(1):81-6. PubMed ID: 6324311
[TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular immune response of sheep to bluetongue virus.
Ghalib HW; Cherrington JM; Adkison MA; Osburn BI
Prog Clin Biol Res; 1985; 178():489-96. PubMed ID: 2989890
[TBL] [Abstract][Full Text] [Related]
19. A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus.
Barros SC; Cruz B; Luís TM; Ramos F; Fagulha T; Duarte M; Henriques M; Fevereiro M
Vet Microbiol; 2009 Jun; 137(3-4):252-9. PubMed ID: 19233575
[TBL] [Abstract][Full Text] [Related]
20. A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep.
Hunter P; Modumo J
Onderstepoort J Vet Res; 2001 Dec; 68(4):331-3. PubMed ID: 12026066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
